Data were analysed from 3616 women aged 49–70 years in a study that enrolled 27 primary care practices and from the multinational WISDOM trial of postmenopausal hormone replacement therapy (HRT), in order to describe menopause symptoms in postmenopausal Māori and non-Māori New Zealand women, and explore relationships between symptoms, sociodemographic profile and postmenopausal HRT use. While Māori and non-Māori differed in demographic and clinical characteristics, few differences were observed in the frequency of menopause-related symptoms. Vasomotor symptoms were reported by 34.4% of women, with no statistically significant difference between Māori and non-Māori (p>0.05). Compared to non-Māori, Māori were less likely to have ever used HRT (24% vs 54%) and to be current HRT users (5% vs 30%; p<0.05).